Alto Neuroscience Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

857.74M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	210.00K	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
MannKind	348.97M
Phathom Pharmaceuticals	175.11M
Xencor	125.58M
Theravance Biopharma	107.46M
MeiraGTx Holdings	81.39M
CytomX Therapeutics	76.20M
Janux Therapeutics	10.00M

Revenue Rankings

ANRO News

7 days ago - Alto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression - Business Wire
27 days ago - Alto Neuroscience Reports Topline Data from Phase 2 Proof-of-Concept Study of ALTO-101 and Highlights Pipeline Advancements - Business Wire
6 weeks ago - Alto Neuroscience Transcript: Stifel 2026 Virtual CNS Forum - Transcripts
6 weeks ago - Alto Neuroscience Announces $120 Million Private Placement Financing - Business Wire
6 weeks ago - Alto Neuroscience Reports Full Year 2025 Financial Results and Recent Business Highlights - Business Wire
6 weeks ago - Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum - Business Wire
2 months ago - Alto Neuroscience Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
2 months ago - Alto Neuroscience Announces Participation in Upcoming Investor Conferences - Business Wire

More News